CLOCK and metabolic disease: Though there is growing interest in using small molecule drugs that target the circadian clock to ameliorate the pathophysiology of metabolic disorder and cancer20,21, little work has been done to study how these compounds can be used to modulate responses to DNA damage caused by cisplatin and other related agents.